🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well ibrutinib with or without bortezomib a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-03-15
Trial ID
NCT03130348
Treatments Being Tested
The purpose of this study is to assess the relative bioavailability (the ex...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02390609
This phase II trial studies how well ibrutinib, fludarabine phosphate, cycl...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-03-18
Trial ID
NCT02629809
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
This phase III trial studies ibrutinib and rituximab to see how well they w...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-03-10
Trial ID
NCT02048813
This is a prospective multicenter phase 2 study designed with the purpose t...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2019-05-15
Trial ID
NCT03980002
Treatments Being Tested
This phase II trial studies how well ibrutinib plus rituximab and lenalidom...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-07-01
Trial ID
NCT03232307
Treatments Being Tested
This phase II trial tests how well venetoclax, ibrutinib, prednisone, obinu...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2025-10-07
Trial ID
NCT06649812
This is a Phase 1/2, multicenter, open-label study to evaluate the efficacy...
Status
Withdrawn
Location
University of Arizona
Start Date
2020-11-18
Trial ID
NCT04607772
This phase I/II trial studies the best dose and side effects of ibrutinib w...
Status
Terminated
Location
Mayo Clinic in Florida
Start Date
2017-03-10
Trial ID
NCT03015792